Microbot Medical (MBOT) Cash & Current Investments (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Cash & Current Investments data on file, last reported at $69.0 million in Q1 2026.

• Quarterly Cash & Current Investments rose 27.04% year-over-year to $69.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.0 million (up 27.04% YoY) and the FY2025 annual result came in at $74.7 million, up 1265.3% from the prior year.
• Cash & Current Investments declined to $69.0 million in Q1 2026, from $74.7 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $74.7 million in Q4 2025 to a low of $3.0 million in Q1 2023.
• A 5-year average of $23.9 million and a median of $8.2 million in 2023 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2023 — Cash & Current Investments sank 76.3% — and 2025, when it surged 1781.44%.
• Tracing MBOT's Cash & Current Investments over 5 years: stood at $8.2 million in 2022, then plunged by 51.65% to $4.0 million in 2023, then jumped by 37.92% to $5.5 million in 2024, then surged by 1265.3% to $74.7 million in 2025, then slipped by 7.55% to $69.0 million in 2026.
• The last three Cash & Current Investments figures came in at $69.0 million (Q1 2026), $74.7 million (Q4 2025), and $73.5 million (Q3 2025), per Business Quant data.